10-Undecen-1-ol

CAS No. 112-43-6

10-Undecen-1-ol( —— )

Catalog No. M27520 CAS No. 112-43-6

10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    10-Undecen-1-ol
  • Note
    Research use only, not for human use.
  • Brief Description
    10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.
  • Description
    10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.(In Vitro):Cobalt-catalyzed step growth polymerization of undec-10-en-1-ol and CO affords aliphatic polyesters (Mn > 10(4) g mol(-1)) based entirely on renewable resources.
  • In Vitro
    Cobalt-catalyzed step growth polymerization of undec-10-en-1-ol and CO affords aliphatic polyesters (Mn 104 g/mol) based entirely on renewable resources.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    platelet-activating factor (PAF)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112-43-6
  • Formula Weight
    170.296
  • Molecular Formula
    C11H22O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (587.23 mM)
  • SMILES
    OCCCCCCCCCC=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Herbert JM, et al. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. J Pharmacol Exp Ther. 1991 Oct;259(1):44-51.
molnova catalog
related products
  • Mucronulatol

    Mucronulatol has anticancer,antiangiogenic activity.

  • debutylbupivacaine

    It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.

  • RGD Trifluoroacetate

    RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.RGD Trifluoroacetate is the most effective and most often employed peptide sequence for stimulated cell adhesion on synthetic surfaces. There are 24 integrins binding to ECM molecules in a RGD dependent manner: α3β1, α5β1, α8β1, αIIbβ3, αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, and to some extent α2β1 and α4β1.